Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for determining human immunodeficiciency virus type 1 (HIV-1) hypersusceptibility to the protease inhibitor amprenavir

Method for determining human immunodeficiciency virus type 1 (HIV-1) hypersusceptibility to the protease inhibitor amprenavir

US Patent 7553618 · Granted Jun 30, 2009

Estimated economic value: $4,959,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods, compositions, and systems for detecting coronavirus neutralizing antibo2025
Methods, compositions, and systems for detecting coronavirus neutralizing antibo2025
Compositions and methods for determining resistance to inhibitors of virus entry2022
Compositions and methods for determining resistance to inhibitors of virus entry2020
Her2 diagnostic methods2019
Compositions and methods for determining whether a subject would benefit from co2019
Methods for determining hypersusceptibility of HIV-1 to non-nucleoside reverse t2019
Methods for evaluating viral receptor/co-receptor usage and inhibitors of virus 2017
Methods for evaluating viral receptor/co-receptor usage and inhibitors of virus 2017
Methods for evaluating viral receptor/co-receptor usage and inhibitors of virus 2017
Compositions and methods for determining whether a subject would benefit from co2017
Methods for determining the presence of antibodies blocking viral infection2015